Results 11 to 20 of about 12,031,157 (316)

Mitochondrial Dynamics in Adult Cardiomyocytes and Heart Diseases

open access: yesFrontiers in Cell and Developmental Biology, 2020
Mitochondria are the powerhouse organelles of cells; they participate in ATP generation, calcium homeostasis, oxidative stress response, and apoptosis. Thus, maintenance of mitochondrial function is critical for cellular functions.
Anqi Li   +4 more
semanticscholar   +1 more source

VEGF-A in Cardiomyocytes and Heart Diseases

open access: yesInternational Journal of Molecular Sciences, 2020
The vascular endothelial growth factor (VEGF), a homodimeric vasoactive glycoprotein, is the key mediator of angiogenesis. Angiogenesis, the formation of new blood vessels, is responsible for a wide variety of physio/pathological processes, including ...
Mariantonia Braile   +8 more
semanticscholar   +1 more source

Biomaterials in Valvular Heart Diseases

open access: yesFrontiers in Bioengineering and Biotechnology, 2020
Valvular heart disease (VHD) occurs as the result of valvular malfunction, which can greatly reduce patient’s quality of life and if left untreated may lead to death. Different treatment regiments are available for management of this defect, which can be
Bita Taghizadeh   +12 more
semanticscholar   +1 more source

Age and gender differences of basic electrocardiographic values and abnormalities in the general adult population; Tehran Cohort Study

open access: yesBMC Cardiovascular Disorders, 2023
Background Although several studies are available regarding baseline Electrocardiographic (ECG) parameters and major and minor ECG abnormalities, there is considerable controversy regarding their age and gender differences in the literature. Methods Data
Pooria Ahmadi   +14 more
doaj   +1 more source

Acute hyperoxia reveals tonic influence of peripheral chemoreceptors on systemic vascular resistance in heart failure patients

open access: yesScientific Reports, 2021
Peripheral chemoreceptors’ (PCh) hyperactivity increases sympathetic tone. An augmented acute ventilatory response to hypoxia, being a marker of PCh oversensitivity, was also identified as a marker of poor prognosis in HF.
Stanislaw Tubek   +5 more
doaj   +1 more source

BMI modifies HDL-C effects on coronary artery bypass grafting outcomes

open access: yesLipids in Health and Disease, 2022
Background Despite the recognized implications of high-density lipoprotein cholesterol (HDL-C) in cardiovascular diseases, the role of body mass index (BMI) in HDL-C association with cardiovascular outcomes remains unclear.
Malihe Rezaee   +12 more
doaj   +1 more source

Major adverse cardiovascular events in patients after acute myocardial infarction treated invasively and different patterns of glucometabolic disturbances evaluated at mid-term follow-up

open access: yesJournal of Medical Science, 2017
Objective:  To assess the impact of glucometabolic status (GS) evaluated at hospital discharge and at mid-term follow-up visit (FU-visit) on major adverse cardiovascular events (MACE) in patients (pts) with acute myocardial infarction (AMI) treated ...
Paweł Francuz   +4 more
doaj   +1 more source

Report on cardiovascular health and diseases in China 2021: an updated summary.

open access: yesJournal of Geriatric Cardiology, 2023
In 2019, cardiovascular disease (CVD) accounted for 46.74% and 44.26% of all deaths in rural and urban areas, respectively. Two out of every five deaths were attributed to CVD.
The Writing Committee Of The Report On Cardiovascular In China   +1 more
semanticscholar   +1 more source

Prognostic significance of positive family history in outcomes after coronary artery bypass grafting: Do we need to update our assumptions?

open access: yesJournal of Cardiothoracic Surgery, 2022
Background Recent research suggests a protective role for positive family history of premature cardiovascular disease (FHpCVD) in patients undergoing coronary artery bypass grafting. We aimed to further investigate this unlikely association.
Hamed Tavolinejad   +12 more
doaj   +1 more source

Efficacy and tolerability of lamivudine plus dolutegravir compared with lamivudine plus boosted PIs in HIV-1 positive individuals with virologic suppression: a retrospective study from the clinical practice

open access: yesBMC Infectious Diseases, 2019
Background Direct comparisons between lamivudine plus bPIs and lamivudine plus dolutegravir as maintenance strategies in virologically-suppressed HIV positive patients are lacking.
Alberto Borghetti   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy